Everolimus and Impurities
Ref: 4Z-E-1036
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-1030
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-1035
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Everolimus-d4 (~90%)
Controlled ProductCAS:1338452-54-2
Applications Macrolide immunosuppressant; derivative of Rapamycin. Inhibits cytokine-mediated lymphocyte proliferation. Not a dangerous good if …
Formula:
C53H4H79NO14
Purity:
~90%
Color and Shape:
White To Light Yellow
Molecular weight:
962.25
Ref: TR-E945402
| 1mg | 401.00 € | ||
| 10mg | 2,709.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Everolimus Retroaldol Degradation Product
Controlled ProductCAS:1708118-13-1
Impurity Everolimus Impurity Stability Light and temperature Sensitive Applications Everolimus Retroaldol Degradation Product is an …
Formula:
C53H83NO14
Color and Shape:
Neat
Molecular weight:
958.22
Ref: TR-E945420
| 1mg | 329.00 € | ||
| 10mg | 2,181.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
31-Oxo Everolimus (~80%)
Controlled ProductFormula:
C53H81NO14
Purity:
~80%
Color and Shape:
Neat
Molecular weight:
956.21
Ref: TR-O856805
| 10mg | 5,546.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
